Journal of Gastroenterology

, Volume 42, Supplement 18, pp 59–62 | Cite as

Prognosis of autoimmune pancreatitis

  • Terumi Kamisawa
  • Atsutake Okamoto


Autoimmune pancreatitis (AIP) is responsive to steroid therapy, but some AIP patients improve spontaneously, or only improve after biliary drainage. Pancreatic enlargement and irregular narrowing of the main pancreatic duct usually improves in almost all patients, but marked atrophy of the pancreas develops in some patients. Biliary stenosis improves to various degrees, and a biliary drainage tube can be withdrawn. Other extrapancreatic lesions, including swelling of the salivary or lacrimal glands, lymphadenopathy, and retroperitoneal fibrosis also improve with steroid therapy. Pancreatic endocrine and exocrine function is frequently impaired in AIP patients, and steroid therapy is occasionally effective for these dysfunction. Deterioration of pancreatic exocrine function is rarely detected after steroid therapy. In the literature, the recurrence rate of AIP was reported to be about 17% (range 6% to 26%). AIP patients who relapse during maintenance steroid therapy or after stopping steroid medication should be re-treated with a high-dose steroid. Although AIP is rarely associated with pancreatic stones, stones are formed in some relapsing AIP patients. The long-term prognosis for AIP is unknown. As the pancreatic exocrine and endocrine functions as well as the morphological findings are reversible after steroid therapy, the prognosis for AIP seems better than that of chronic pancreatitis, which is usually followed by exocrine and endocrine pancreatic insufficiency with disease progression. Although carcinogenesis of AIP is unknown, some AIP patients developed a malignancy during follow-up. Since AIP occurs predominantly in the elderly, clinicians should pay attention to any complicating diseases in follow-up of AIP patients. Further studies are necessary to clarify the pathogenesis as well as the long-term prognosis of AIP.

Key words

autoimmune pancreatitis steroid prognosis diabetes mellitus 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kamisawa, T, Okamoto, A 2006Autoimmune pancreatitis. Proposal of IgG4-related sclerosing diseaseJ Gastroenterol4161325PubMedCrossRefGoogle Scholar
  2. 2.
    Kamisawa, T, Egawa, N, Nakajima, H, Tsuruta, K, Okamoto, A, Kamata, N 2003Clinical difficulties in the differentiation of autoimmune pancreatitis and pancreatic carcinomaAm J Gastroenterol9826949PubMedCrossRefGoogle Scholar
  3. 3.
    Kamisawa, T, Egawa, N, Nakajima, H, Tsuruta, K, Okamoto, A 2005Extrapancreatic lesions in autoimmune pancreatitisJ Clin Gastroenterol399047PubMedCrossRefGoogle Scholar
  4. 4.
    Kamisawa, T, Nakajima, H, Egawa, N, Funata, N, Tsuruta, K, Okamoto, A 2006IgG4-related sclerosing disease incorporating sclerosing pancreatitis, cholangitis, sialadenitis and retroperitoneal fibrosis with lymphadenopathyPancreatology61327PubMedCrossRefGoogle Scholar
  5. 5.
    Kamisawa, T, Egawa, N, Nakajima, H, Tsuruta, K, Okamoto, A 2004Morphological changes after steroid therapy in autoimmune pancreatitisScand J Gastroenterol3911548PubMedCrossRefGoogle Scholar
  6. 6.
    Kamisawa, T, Yoshiike, M, Egawa, N, Nakajima, H, Tsuruta, K, Okamoto, A 2005Treating patients with autoimmune pancreatitis: results from a long-term follow-up studyPancreatology523440PubMedCrossRefGoogle Scholar
  7. 7.
    Nishino, T, Toki, F, Oyama, H, Shimizu, K, Shiratori, K 2006Long-term outcome of autoimmune pancreatitis after oral prednisolone therapyIntern Med45497501PubMedCrossRefGoogle Scholar
  8. 8.
    Wakabayashi, T, Kawaura, Y, Satomura, Y, Watanabe, H, Motoo, Y, Sawabu, N 2005Long-term prognosis of duct-narrowing chronic pancreatitis. Strategy for steroid treatmentPancreas30319PubMedGoogle Scholar
  9. 9.
    Ozden, I, Dizdaroglu, F, Poyanli, A, Emre, A 2005Spontaneous regression of a pancreatic head mass and biliary obstruction due to autoimmune pancreatitisPancreatology53003PubMedCrossRefGoogle Scholar
  10. 10.
    Kamisawa, T, Egawa, N, Inokuma, S, Tsuruta, K, Okamoto, A, Kamata, N,  et al. 2003Pancreatic endocrine and exocrine function and salivary gland function in autoimmune pancreatitis before and after steroid therapyPancreas272358PubMedCrossRefGoogle Scholar
  11. 11.
    Kamisawa, T, Nakamura, T, Egawa, N, Nakajima, H, Tsuruta, K, Okamoto, A 2006Digestion and absorption of patients with autoimmune pancreatitisHepatogastroenterology5313840PubMedGoogle Scholar
  12. 12.
    Takayama, M, Hamano, H, Ochi, Y, Saegusa, H, Komatsu, K, Muraki, T,  et al. 2004Recurrent attacks of autoimmune pancreatitis result in pancreatic stone formationAm J Gastroenterol999327PubMedCrossRefGoogle Scholar
  13. 13.
    Zamboni, G, Luttges, J, Capelli, P, Frulloni, L, Cavallini, G, Pederzoli, P,  et al. 2004Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study of 53 resection specimens and 9 biopsy specimensVirchow Arch44555263CrossRefGoogle Scholar
  14. 14.
    Kim, KP, Kim, MH, Dong, MH, Lee, SS, Seo, DW, Lee, SK 2004Autoimmune chronic pancreatitisAm J Gastroenterol99160516PubMedCrossRefGoogle Scholar
  15. 15.
    Taniguchi, T, Tanio, H, Seko, S, Nishida, O, Inoue, F, Okamoto, M,  et al. 2003Autoimmune pancreatitis detected as a mass in the head of the pancreas without hypergammaglobulinemia, which relapsed after surgery. Case report and review of the literatureDig Dis Sci48146571PubMedCrossRefGoogle Scholar
  16. 16.
    Padilla, D, Cubo, T, VilLarejo, P, Pardo, R, Jara, A, de La Plaza, R,  et al. 2005Response to steroid therapy of sclerosing cholangitis after duodenopancreatectomy due to autoimmune pancreatitisGut5413489PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Tokyo 2007

Authors and Affiliations

  • Terumi Kamisawa
    • 1
  • Atsutake Okamoto
    • 2
  1. 1.Department of MedicineTokyo Metropolitan Komagome HospitalTokyoJapan
  2. 2.Department of SurgeryTokyo Metropolitan Komagome HospitalTokyoJapan

Personalised recommendations